{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:24:51Z","timestamp":1791584691151,"version":"4.3.4"},"reference-count":195,"publisher":"Wiley","issue":"14","license":[{"start":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T00:00:00Z","timestamp":1624492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Medicine"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Traditional cancer therapy has many disadvantages such as low selectivity and high toxicity of chemotherapy, as well as insufficient efficacy of targeted therapy. To enhance the cytotoxic effect and targeting ability, while reducing the toxicity of antitumor drugs, an antibody drug conjugate (ADC) was developed to deliver small molecular cytotoxic payloads directly to tumor cells by binding to specific antibodies via linkers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>By reviewing published literature and the current progress of ADCs, we aimed to summarize the basic characteristics, clinical progress, and challenges of ADCs to provide a reference for clinical practice and further research.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>ADC is a conjugate composed of three fundamental components, including monoclonal antibodies, cytotoxic payloads, and stable linkers. The mechanisms of ADC including the classical internalization pathway, antitumor activity of antibodies, bystander effect, and non\u2010internalizing mechanism. With the development of new drugs and advances in technology, various ADCs have achieved clinical efficacy. To date, nine ADCs have received US Food and Drug Administration (FDA) approval in the field of hematologic tumors and solid tumors, which have become routine clinical treatments.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>ADC has changed traditional treatment patterns for cancer patients, which enable the same treatment for pancreatic cancer patients and promote individualized precision treatment. Further exploration of indications could focus on early\u2010stage cancer patients and combined therapy settings. Besides, the mechanisms of drug resistance, manufacturing techniques, optimized treatment regimens, and appropriate patient selection remain the major topics.<\/jats:p><\/jats:sec>","DOI":"10.1002\/cam4.4052","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T11:08:04Z","timestamp":1624532884000},"page":"4677-4696","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["The promising role of antibody drug conjugate in cancer therapy: Combining targeting ability with cytotoxicity effectively"],"prefix":"10.1002","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6832-5950","authenticated-orcid":false,"given":"Wen\u2010Qian","family":"Li","sequence":"first","affiliation":[{"name":"Department of Cancer Center The First Hospital of Jilin University Changchun Jilin China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5897-3145","authenticated-orcid":false,"given":"Han\u2010Fei","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Cancer Center The First Hospital of Jilin University Changchun Jilin China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling\u2010Yu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cancer Center The First Hospital of Jilin University Changchun Jilin China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong\u2010Fei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cancer Center The First Hospital of Jilin University Changchun Jilin China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6496-7550","authenticated-orcid":false,"given":"Jiu\u2010Wei","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Cancer Center The First Hospital of Jilin University Changchun Jilin China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,6,24]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104932"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djz035"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1039\/C8CS00676H"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.11.034"},{"issue":"3","key":"e_1_2_9_6_1","first-page":"228","article-title":"Antibody\u2010drug conjugates: the new generation of biotechnological therapies against cancer","volume":"156","author":"Melgarejo\u2010Rubio G","year":"2020","journal-title":"Gac Med Mex"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-017-0619-0"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/protein\/gzl013"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201903498"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi5015216"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/protein\/gzw040"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00520"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201307628"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28967"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.435"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3253"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27419"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2007.04.010"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2016.07.012"},{"issue":"2","key":"e_1_2_9_20_1","first-page":"33","article-title":"DNA damaging agent\u2010based antibody\u2010drug conjugates for cancer therapy","volume":"1","author":"Fu Y","year":"2018","journal-title":"Antib Ther"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-11-1040"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-015-1657-7"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-014-9710-8"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2016.1156829"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-016-0323-0"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.0c01622"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0786-6"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.2174\/1568026618666180118155847"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403205"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00470-8"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-019-0342-2"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-061516-121357"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31774-X"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.accounts.8b00537"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2015.04.002"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-10-535088"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-3973"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.119.262287"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.367"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI120481"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-3179"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0604"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2020-0026"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-020-00561-w"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00905-2"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01175-0"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01404-x"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-0012"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.102033"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01281-4"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01337-5"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01241-7"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1089-8"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1177\/1533033820945815"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404434"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.986478"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-019-0690-2"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.141622"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.244"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.096545"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2018.02.017"},{"key":"e_1_2_9_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-014-2229-3"},{"key":"e_1_2_9_63_1","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyaa117"},{"key":"e_1_2_9_64_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102887"},{"key":"e_1_2_9_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2607"},{"key":"e_1_2_9_66_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.0410"},{"key":"e_1_2_9_67_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-02-699850"},{"key":"e_1_2_9_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60165-9"},{"key":"e_1_2_9_69_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-07-861641"},{"key":"e_1_2_9_70_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-1803"},{"key":"e_1_2_9_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.07.018"},{"key":"e_1_2_9_72_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz009"},{"key":"e_1_2_9_73_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.1834.1834"},{"key":"e_1_2_9_74_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-11-815183"},{"issue":"4","key":"e_1_2_9_75_1","article-title":"Combining brentuximab vedotin with dexamethasone, high\u2010dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON\/LLPC Transplant BRaVE study","volume":"106","author":"Kersten MJ","year":"2021","journal-title":"Haematologica"},{"key":"e_1_2_9_76_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-10-811224"},{"key":"e_1_2_9_77_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.0402"},{"key":"e_1_2_9_78_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-05-780049"},{"key":"e_1_2_9_79_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-12-542142"},{"key":"e_1_2_9_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31266-7"},{"key":"e_1_2_9_81_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-09-598763"},{"key":"e_1_2_9_82_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01492"},{"key":"e_1_2_9_83_1","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-6-40"},{"key":"e_1_2_9_84_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509277"},{"key":"e_1_2_9_85_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32116"},{"key":"e_1_2_9_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(17)30103-5"},{"key":"e_1_2_9_87_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.2380"},{"key":"e_1_2_9_88_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31720"},{"key":"e_1_2_9_89_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.7211"},{"key":"e_1_2_9_90_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2488"},{"key":"e_1_2_9_91_1","doi-asserted-by":"publisher","DOI":"10.1080\/21556660.2017.1315336"},{"key":"e_1_2_9_92_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14820"},{"key":"e_1_2_9_93_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.03418"},{"key":"e_1_2_9_94_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00172"},{"key":"e_1_2_9_95_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003323"},{"key":"e_1_2_9_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30788-0"},{"key":"e_1_2_9_97_1","unstructured":"NookaAKMM BahlisN WeiselK et al.DREAMM\u20104: evaluating safety and clinical activity of belantamab mafodotin in combination with pembrolizumab in patients with relapsed\/refractory multiple myeloma (RRMM).European Haematology Association (EHA) Congress.2020;EP955."},{"issue":"1","key":"e_1_2_9_98_1","first-page":"19\u201020","article-title":"DREAMM\u20106: safety and tolerability of belantamab mafodotin in combination with bortezomib\/dexamethasone in relapsed\/refractory multiple myeloma","volume":"136","author":"Nooka AKGK","year":"2020","journal-title":"Blood"},{"key":"e_1_2_9_99_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00962-7"},{"key":"e_1_2_9_100_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.0060"},{"key":"e_1_2_9_101_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.188888"},{"key":"e_1_2_9_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60485-1"},{"key":"e_1_2_9_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70281-5"},{"key":"e_1_2_9_104_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25057"},{"key":"e_1_2_9_105_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.49.0771"},{"key":"e_1_2_9_106_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001278"},{"key":"e_1_2_9_107_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708984"},{"key":"e_1_2_9_108_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003127"},{"key":"e_1_2_9_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32984-2"},{"key":"e_1_2_9_110_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0098"},{"key":"e_1_2_9_111_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001821"},{"key":"e_1_2_9_112_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.104.104"},{"key":"e_1_2_9_113_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.238675"},{"key":"e_1_2_9_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30011-1"},{"key":"e_1_2_9_115_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-019-0160-4"},{"key":"e_1_2_9_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30091-9"},{"key":"e_1_2_9_117_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0266-x"},{"key":"e_1_2_9_118_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-020-0388-9"},{"key":"e_1_2_9_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2015.08.006"},{"key":"e_1_2_9_120_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2017.179"},{"key":"e_1_2_9_121_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm500766w"},{"key":"e_1_2_9_122_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1209124"},{"key":"e_1_2_9_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30312-1"},{"key":"e_1_2_9_124_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu486"},{"key":"e_1_2_9_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2019.07.010"},{"key":"e_1_2_9_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.06.020"},{"key":"e_1_2_9_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70178-0"},{"key":"e_1_2_9_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30313-3"},{"key":"e_1_2_9_129_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00858"},{"key":"e_1_2_9_130_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30111-0"},{"key":"e_1_2_9_131_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-018-00923-7"},{"key":"e_1_2_9_132_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.77.9777"},{"key":"e_1_2_9_133_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-1590"},{"key":"e_1_2_9_134_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2020.1792443"},{"key":"e_1_2_9_135_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1914510"},{"key":"e_1_2_9_136_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2004413"},{"key":"e_1_2_9_137_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-1014"},{"key":"e_1_2_9_138_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00118"},{"key":"e_1_2_9_139_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-3321"},{"key":"e_1_2_9_140_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1814213"},{"key":"e_1_2_9_141_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.09.004"},{"key":"e_1_2_9_142_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.7_suppl.354"},{"key":"e_1_2_9_143_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.72.1894"},{"key":"e_1_2_9_144_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-0933"},{"key":"e_1_2_9_145_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02044"},{"key":"e_1_2_9_146_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01140"},{"key":"e_1_2_9_147_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.4887"},{"key":"e_1_2_9_148_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2019.12.010"},{"issue":"5","key":"e_1_2_9_149_1","article-title":"EV\u2010103: initial results of enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma","volume":"30","author":"Hoimes CJ","year":"2019","journal-title":"Ann Oncol"},{"key":"e_1_2_9_150_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1814017"},{"key":"e_1_2_9_151_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3980"},{"key":"e_1_2_9_152_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30716-7"},{"key":"e_1_2_9_153_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00882"},{"key":"e_1_2_9_154_1","first-page":"1","article-title":"Antibody\u2010drug conjugates: patient and treatment selection","volume":"40","author":"Makawita S","year":"2020","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"e_1_2_9_155_1","unstructured":"The 2020 Cortellis Drugs to Watch.https:\/\/www.bioworld.com\/articles\/432945\u2010the\u20102020\u2010cortellis\u2010drugs\u2010to\u2010watch"},{"key":"e_1_2_9_156_1","doi-asserted-by":"publisher","DOI":"10.1080\/21691401.2018.1449119"},{"key":"e_1_2_9_157_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-020-01153-5"},{"key":"e_1_2_9_158_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.07.012"},{"key":"e_1_2_9_159_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0215"},{"key":"e_1_2_9_160_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-015-1624-3"},{"key":"e_1_2_9_161_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210477"},{"key":"e_1_2_9_162_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph11020032"},{"key":"e_1_2_9_163_1","doi-asserted-by":"publisher","DOI":"10.3390\/antib7010011"},{"key":"e_1_2_9_164_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-010-1090-x"},{"key":"e_1_2_9_165_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-08-0295"},{"key":"e_1_2_9_166_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2016.268"},{"key":"e_1_2_9_167_1","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20150089"},{"key":"e_1_2_9_168_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-1417"},{"key":"e_1_2_9_169_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2019.05.031"},{"key":"e_1_2_9_170_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ddtec.2018.10.005"},{"key":"e_1_2_9_171_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2018.12.035"},{"key":"e_1_2_9_172_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b00457"},{"key":"e_1_2_9_173_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.05.010"},{"key":"e_1_2_9_174_1","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.9b05833"},{"key":"e_1_2_9_175_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-015-0466-9"},{"key":"e_1_2_9_176_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba6752"},{"key":"e_1_2_9_177_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1480"},{"issue":"1","key":"e_1_2_9_178_1","first-page":"3","article-title":"Antibody\u2010drug conjugates: possibilities and challenges","volume":"11","author":"Nejadmoghaddam MR","year":"2019","journal-title":"Avicenna J Med Biotechnol"},{"key":"e_1_2_9_179_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.08.975"},{"key":"e_1_2_9_180_1","unstructured":"Mersana Therapeutics. XMT\u20101536.https:\/\/www.mersana.com\/pipeline\/xmt\u20101536\/"},{"key":"e_1_2_9_181_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-019-0470-8"},{"key":"e_1_2_9_182_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-014-1536-7"},{"key":"e_1_2_9_183_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S150317"},{"key":"e_1_2_9_184_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-0272"},{"key":"e_1_2_9_185_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-466706"},{"key":"e_1_2_9_186_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.141937"},{"key":"e_1_2_9_187_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1730-1"},{"key":"e_1_2_9_188_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-18-0314"},{"key":"e_1_2_9_189_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-2401"},{"key":"e_1_2_9_190_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2020.01.037"},{"key":"e_1_2_9_191_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2020.05.039"},{"key":"e_1_2_9_192_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2015.12.008"},{"key":"e_1_2_9_193_1","doi-asserted-by":"publisher","DOI":"10.1021\/bc200212a"},{"key":"e_1_2_9_194_1","doi-asserted-by":"publisher","DOI":"10.2174\/138920012802138598"},{"key":"e_1_2_9_195_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-017-0519-6"},{"key":"e_1_2_9_196_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.13.3244"}],"container-title":["Cancer Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cam4.4052","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cam4.4052","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cam4.4052","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T21:03:46Z","timestamp":1693343026000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cam4.4052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,24]]},"references-count":195,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.1002\/cam4.4052"],"URL":"https:\/\/doi.org\/10.1002\/cam4.4052","archive":["Portico"],"relation":{},"ISSN":["2045-7634","2045-7634"],"issn-type":[{"value":"2045-7634","type":"print"},{"value":"2045-7634","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,24]]},"assertion":[{"value":"2021-03-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}